Open an account

Zynex

ZYXI · NASDAQ

Price unavailable right now.

No price history for this range.

About ZYXI

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.

Employees
1,000
Headquarters
Englewood, Colorado
Listed
Nov 27, 2002
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
zynex.com

ZYXI key statistics

This section is temporarily unavailable. Refresh to try again.

ZYXI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 21.1% on average.

  1. Q4 FY23: reported $0.21 per share against an estimate of $0.1734
  2. Q1 FY24: reported $0.00 per share against an estimate of $0.034
  3. Q2 FY24: reported $0.04 per share against an estimate of $0.0782
  4. Q3 FY24: reported $0.07 per share against an estimate of $0.0578
  5. Q4 FY24: reported -$0.02 per share against an estimate of $0.0918
  6. Q1 FY25: reported -$0.33 per share against an estimate of -$0.2448
  7. Q2 FY25: reported -$0.66 per share against an estimate of -$0.2006
  8. Q3 FY25: reported -$0.40 per share against an estimate of -$0.1785

ZYXI news

  • Press releasePRNewswire

    Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm

  • Press releasePRNewswire

    ZYXI ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

  • Press releasePRNewswire

    Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

  • Press releasePRNewswire

    Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

  • Press releasePRNewswire

    Zynex Investor Alert: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

  • Avi Kapoor

    Crude Oil Falls Sharply; SRX Health Solutions Shares Jump

  • Press releasePRNewswire

    Zynex Financial Restructuring Puts Company on Path to Long-Term Success

  • 12 Health Care Stocks Moving In Friday's Intraday Session

Similar companies

Companies in the same industry as Zynex

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.